VEGFA and hepatocellular carcinoma: During the decades, several monoclonal antibodies (mAbs) have been successfully used in clinical patients for the treatment of human cancer, such as antagonists of VEGF, bevacizumab for colorectal cancer, ramucirumab for HCC and so on 113, 114.